Short Interest in Adagio Therapeutics, Inc. (NASDAQ:ADGI) Decreases By 14.0%

Adagio Therapeutics, Inc. (NASDAQ:ADGI – Get Rating) was the target of a significant decline in short interest in April. As of April 30th, there was short interest totalling 4,960,000 shares, a decline of 14.0% from the April 15th total of 5,770,000 shares. Based on an average daily volume of 3,560,000 shares, the short-interest ratio is […]

Related Keywords

New York ,United States ,Canada ,Stifel Nicolaus ,Morgan Stanley ,York State Common Retirement Fund ,Adagio Therapeutics Inc ,Nasdaq ,Charles Schwab Investment Management Inc ,Adagio Therapeutics Company Profile Get Rating ,Citigroup Inc ,Royal Bank ,Adagio Therapeutics ,Get Rating ,Schwab Investment Management ,Therapeutics Company Profile ,Nasdaq Adgi ,Amadgi ,Medical ,Stocks ,Options ,Put ,Call ,